Simultaneous inactivation of TP53 and loss of PTEN diminish response to targeted therapy in V600EBRAF mutant melanoma
Authors
Galvani, ElenaBrooks, Kelly
Baenke, Franziska
Girotti, Maria Romina
Gremel, Gabriela
Mandal, Amit Kumar
Viros, Amaya
McManus, Clare
Smith, Matthew
Lim, Kok Haw Jonathan
Lee, Rebecca J
Fusi, Alberto
Lorigan, Paul C
Marais, Richard
Affiliation
Cancer Research UK Manchester Institute, ManchesterIssue Date
2015